title: Gold nanoparticle mediated cancer immunotherapy.
abstract: Significant progress has been made in the field of cancer immunotherapy, where the goal is to activate or modulate the body's immune response against cancer. However, current immunotherapy approaches exhibit limitations of safety and efficacy due to systemic delivery. In this context, the use of nanotechnology for the delivery of cancer vaccines and immune adjuvants presents a number of advantages such as targeted delivery to immune cells, enhanced therapeutic effect, and reduced adverse outcomes. Recently, gold nanoparticles (AuNP) have been explored as immunotherapy carriers, creating new AuNP applications that merit a critical overview. This review highlights recent advances in the development of AuNP mediated immunotherapies that harness AuNP biodistribution, optical properties and their ability to deliver macromolecules such as peptides and oligonucleotides. It has been demonstrated that the use of AuNP carriers can improve the delivery and safety of immunotherapy agents, and that AuNP immunotherapies are well suited for synergistic combination therapy with existing cancer therapies like photothermal ablation.
  
  
  BACKGROUND
  Cancer immunotherapy approaches are rapidly evolving and are some of the most promising avenues to approach malignancies. This review summarizes the role of gold nanoparticles in immunotherapy agent delivery, and in the development of synergistic therapies such as photothermal ablation.
authors.affiliation: Department of Bioengineering, Rice University, Houston, TX, USA.
authors.forename: Joao Paulo Mattos
authors.initials: JP
authors.lastname: Almeida
authors.affiliation: Department of Bioengineering, Rice University, Houston, TX, USA.
authors.forename: Elizabeth Raquel
authors.initials: ER
authors.lastname: Figueroa
authors.affiliation: Department of Bioengineering, Rice University, Houston, TX, USA. Electronic address: drezek@rice.edu.
authors.forename: Rebekah Anna
authors.initials: RA
authors.lastname: Drezek
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000627:therapeutic use; D004337:Drug Carriers / Q000737:chemistry* / Q000493:pharmacokinetics; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D006046:Gold / Q000737:chemistry* / Q000276:immunology / Q000493:pharmacokinetics; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D050997:Nanomedicine / Q000379:methods*; D053758:Nanoparticles / Q000737:chemistry* / Q000378:metabolism; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*
chemical_list: D000276:Adjuvants, Immunologic; D019496:Cancer Vaccines; D004337:Drug Carriers; D006046:Gold
keywords: Biodistribution; Cancer; Gold nanoparticles; Immune system; Immunotherapy